BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 33302892)

  • 1. Combination of biomarker with clinical risk factors for prediction of severe acute kidney injury in critically ill patients.
    Jia L; Sheng X; Zamperetti A; Xie Y; Corradi V; Chandel S; De Cal M; Montin DP; Caprara C; Ronco C
    BMC Nephrol; 2020 Dec; 21(1):540. PubMed ID: 33302892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein-7 (IGFBP7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury.
    Xie Y; Ankawi G; Yang B; Garzotto F; Passannante A; Breglia A; Digvijay K; Ferrari F; Brendolan A; Raffaele B; Giavarina D; Gregori D; Ronco C
    Kidney Int; 2019 Jun; 95(6):1486-1493. PubMed ID: 30982674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker Rule-in or Rule-out in Patients With Acute Diseases for Validation of Acute Kidney Injury in the Emergency Department (BRAVA): A Multicenter Study Evaluating Urinary TIMP-2/IGFBP7.
    Yang HS; Hur M; Lee KR; Kim H; Kim HY; Kim JW; Chua MT; Kuan WS; Chua HR; Kitiyakara C; Phattharapornjaroen P; Chittamma A; Werayachankul T; Anandh U; Herath S; Endre Z; Horvath AR; Antonini P; Di Somma S;
    Ann Lab Med; 2022 Mar; 42(2):178-187. PubMed ID: 34635611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue Inhibitor Metalloproteinase-2·IGF-Binding Protein 7 for the Prediction of Acute Kidney Injury following Cardiac Surgery.
    Xie Y; Guo Q; Yang B; Xie P; Zhang J; Lu W; Ronco C; Jiang G
    Cardiorenal Med; 2024; 14(1):251-260. PubMed ID: 38588650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Acute Kidney Injury in Intensive Care Unit Patients: The Role of Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor-Binding Protein-7 Biomarkers.
    Di Leo L; Nalesso F; Garzotto F; Xie Y; Yang B; Virzì GM; Passannante A; Bonato R; Carta M; Giavarina D; Gregori D; Brendolan A; Ferrari F; Ronco C
    Blood Purif; 2018; 45(1-3):270-277. PubMed ID: 29478052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of patients' clinical features at intensive care unit admission on performance of cell cycle arrest biomarkers in predicting acute kidney injury.
    Yang B; Xie Y; Garzotto F; Ankawi G; Passannante A; Brendolan A; Bonato R; Carta M; Giavarina D; Vidal E; Gregori D; Ronco C
    Clin Chem Lab Med; 2020 Sep; 59(2):333-342. PubMed ID: 32986608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers.
    Dusse F; Edayadiyil-Dudásova M; Thielmann M; Wendt D; Kahlert P; Demircioglu E; Jakob H; Schaefer ST; Pilarczyk K
    BMC Anesthesiol; 2016 Sep; 16():76. PubMed ID: 27609347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients.
    Gunnerson KJ; Shaw AD; Chawla LS; Bihorac A; Al-Khafaji A; Kashani K; Lissauer M; Shi J; Walker MG; Kellum JA;
    J Trauma Acute Care Surg; 2016 Feb; 80(2):243-9. PubMed ID: 26816218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum procalcitonin levels predict acute kidney injury in critically ill patients.
    Jeeha R; Skinner DL; De Vasconcellos K; Magula NP
    Nephrology (Carlton); 2018 Dec; 23(12):1090-1095. PubMed ID: 28967168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest.
    Cummings JJ; Shaw AD; Shi J; Lopez MG; O'Neal JB; Billings FT
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1545-1553.e5. PubMed ID: 30389130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction of a risk predictive model of acute kidney injury based on urinary tissue inhibitor of metalloproteinase 2 and insulin-like growth factor-binding protein 7 and its early predictive value in critically ill patients].
    Wang H; Mou H; Xu X; Zheng R
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Apr; 36(4):387-391. PubMed ID: 38813633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury.
    Westhoff JH; Tönshoff B; Waldherr S; Pöschl J; Teufel U; Westhoff TH; Fichtner A
    PLoS One; 2015; 10(11):e0143628. PubMed ID: 26606754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary cell cycle arrest biomarkers and chitinase 3-like protein 1 (CHI3L1) to detect acute kidney injury in the critically ill: a post hoc laboratory analysis on the FINNAKI cohort.
    Hoste EA; Vaara ST; De Loor J; Haapio M; Nuytinck L; Demeyere K; Pettilä V; Meyer E;
    Crit Care; 2020 Apr; 24(1):144. PubMed ID: 32276601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary [TIMP-2] × [IGFBP7] and serum procalcitonin to predict and assess the risk for short-term outcomes in septic and non-septic critically ill patients.
    Godi I; De Rosa S; Martino F; Bazzano S; Martin M; Boni E; Carta MR; Tamayo Diaz C; Mari G; Lorenzin A; de Cal M; Corradi V; Caprara C; Giavarina D; Ronco C
    Ann Intensive Care; 2020 Apr; 10(1):46. PubMed ID: 32318859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness.
    McCullough PA; Ostermann M; Forni LG; Bihorac A; Koyner JL; Chawla LS; Shi J; Kampf JP; McPherson P; Kellum JA;
    Cardiorenal Med; 2019; 9(6):358-369. PubMed ID: 31618746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients.
    Daubin D; Cristol JP; Dupuy AM; Kuster N; Besnard N; Platon L; Buzançais A; Brunot V; Garnier F; Jonquet O; Klouche K
    PLoS One; 2017; 12(1):e0169674. PubMed ID: 28085896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker Predictors of Adverse Acute Kidney Injury Outcomes in Critically Ill Patients: The Dublin Acute Biomarker Group Evaluation Study.
    McMahon BA; Galligan M; Redahan L; Martin T; Meaney E; Cotter EJ; Murphy N; Hannon C; Doran P; Marsh B; Nichol A; Murray PT
    Am J Nephrol; 2019; 50(1):19-28. PubMed ID: 31203271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIMP-2/IGFBP7 predicts acute kidney injury in out-of-hospital cardiac arrest survivors.
    Adler C; Heller T; Schregel F; Hagmann H; Hellmich M; Adler J; Reuter H
    Crit Care; 2018 May; 22(1):126. PubMed ID: 29751827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.
    Vijayan A; Faubel S; Askenazi DJ; Cerda J; Fissell WH; Heung M; Humphreys BD; Koyner JL; Liu KD; Mour G; Nolin TD; Bihorac A;
    Am J Kidney Dis; 2016 Jul; 68(1):19-28. PubMed ID: 26948834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical adoption of Nephrocheck® in the early detection of acute kidney injury.
    Ilaria G; Kianoush K; Ruxandra B; Francesca M; Mariarosa C; Davide G; Claudio R
    Ann Clin Biochem; 2021 Jan; 58(1):6-15. PubMed ID: 33081495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.